Loading...

MREO MEREO BIOPHARMA GROUP PLC Management Changes 8-K Filing

MR B

MR

MEREO BIOPHARMA GROUP PLC

(MREO)

2025 8-K

Director Resignation

Financial Results Announced

Delisting Notification

Clinical Study Results

Q3 Financial Results

Product Expansion

Financial Statements

Financial Results

Clinical Update

License Agreement Update

Q2 Financial Results

Underwriting Agreement

Interim Data from Phase 2/3...

Financial Results Announcement

Extension Agreement with Ru...

Financial Results Announcement

External Links:

On May 13, 2025, Mereo BioPharma Group plc held its 2025 Annual General Meeting where all resolutions were passed except for the vote frequency on executive compensation, which will now be submitted annually until 2031.

AI Assistant

MEREO BIOPHARMA GROUP PLC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.